First Ascent Biomedical, a 2022 graduate of the Fire Accelerator program sponsored by the Erie Regional Chamber and Growth ...

Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the “Company”), a leader in PCR-based DNA technologies, today announced that Applied DNA Clinical Labs (ADCL), the Company’s wholly-owned ...

The USA is expected to witness a CAGR of 6.2% in the Cryo Box Market from 2025 to 2035. The UK is projected to experience a CAGR of 6.9% during the same period. The European Union region is estimated ...

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common chronic diseases like heart disease, diabetes, and cancer.

The pathogen C. diff — the most common cause of health care-associated infectious diarrhea — can use a compound that kills ...

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common ...

A DNA nanomachine selectively targets skin cancer by detecting microRNA-7, activating phototherapy and releasing chemotherapy ...

Along with nitrogen and carbon, phosphorus is an essential element for life on Earth. It is a central component of molecules ...

Mouse cells tweaked to produce the tardigrade protein incurred less DNA damage than unaltered cells — hinting at a new tool for cancer patient care.

Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine ...

This study provides a potentially useful investigation into the positive role of BDNF/TrkB signaling in implanted dental pulp stem cells to enhance dentin regeneration in the context of dental caries.

Customers looking for an mRNA therapeutic partner should prioritize operational excellence and choose flexible CDMOs.